Biotech Firm iBio Gets Green Light for Future Capital Raising Options

Rhea-AI Filing Summary

The SEC has declared iBio's Form S-3 registration statement effective as of June 23, 2025, at 5:00 P.M. The registration statement was filed under file number 333-288000.

Form S-3 is a simplified security registration form used by companies that have already met certain reporting requirements. This effectiveness notice indicates that:

• iBio can now proceed with its planned securities offering
• The company has satisfied SEC registration requirements
• The registration statement has been reviewed and approved by the SEC

This filing suggests iBio is preparing to raise capital through the public markets, though specific details about the type and amount of securities to be offered would be found in the original S-3 filing and related prospectus.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 23, 2025 5:00 P.M.

Form:

S-3

CIK:	0001420720
Company Name:	iBio, Inc.
File Number:	333-288000

FAQ

What type of SEC filing did IBIO submit that became effective on June 23, 2025?

IBIO submitted a Form S-3 registration statement that became effective on June 23, 2025 at 5:00 P.M. The Form S-3 was filed under file number 333-288000.

What is IBIO's CIK number on their Form S-3 filing?

IBIO's CIK (Central Index Key) number is 0001420720 as shown on their Form S-3 registration statement.

When did IBIO's Form S-3 registration statement become effective?

IBIO's Form S-3 registration statement became effective on June 23, 2025 at 5:00 P.M. as indicated in the SEC Notice of Effectiveness.

What is the file number for IBIO's Form S-3 registration statement?

The file number for IBIO's Form S-3 registration statement is 333-288000.